SCHEMBL1470682

SCHEMBL1470682

CC(C)Nc1ccccc1NCCN(Cc1cc(C(=O)N2CCCCC2)cs1)C(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.40
CNR2 P34972 1/20 0.37
MAPK1 P28482 2/20 0.36
HPGD P15428 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
USP2 O75604 1/20 0.36
ALOX15 P16050 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
EHMT2 Q96KQ7 1/20 0.33
ABL1 P00519 1/20 0.33
RIN1 Q13671 1/20 0.33
KMT2A Q03164 2/20 0.33
APP P05067 1/20 0.33
GLA P06280 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1471054 0.89 CNR2 (0.37) HRH3CNR2MAPK1HPGDALDH1A1
SCHEMBL1470893 0.86 SMN1; SMN2 (0.40) CNR2MAPK1HPGDALDH1A1MAPT
SCHEMBL1470908 0.86 HTR1A (0.42) CNR2HPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL1470960 0.79 HRH3 (0.46) HRH3MAPK1HPGDALDH1A1MAPT
SCHEMBL1471442 0.76 HTR1A (0.52) KMT2AMEN1GAAHTT
SCHEMBL1471446 0.75 HDAC1 (0.41) CNR2HPGDALDH1A1TDP1KMT2A
SCHEMBL1470736 0.75 NPC1 (0.41) CNR2HPGDALDH1A1MAPTKMT2A
SCHEMBL1470751 0.73 SMN1; SMN2 (0.42) CNR2MAPK1HPGDALDH1A1MAPT
SCHEMBL8306315 0.70 KMT2A (0.51) ALDH1A1KMT2ATSHRSMN1; SMN2MEN1
SCHEMBL1470926 0.69 HRH3 (0.43) HRH3HPGDMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915420-B2 Aryl piperidine amides JANSSEN PHARMACEUTICA NV (BE) 2011-03-29 US disclosed
US-20080009521-A1 Aryl Piperidine Amides HUANG CHARLES Q 2008-01-10 US disclosed
US-7276610-B2 Aryl piperidine amides JANSSEN PHARACEUTICA, NV (BE) 2007-10-02 US disclosed
US-20050049239-A1 Aryl piperidine amides JANSSEN PHARMACEUTICA, N.V. (BE) 2005-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009521-A1 Aryl Piperidine Amides BDNF, NTRK2, OPRL1 HRH3 1790/4885CNR2 67/4885MAPK1 1699/4885
US-20050049239-A1 Aryl piperidine amides BDNF, NTRK2, OPRL1 HRH3 1790/4885CNR2 67/4885MAPK1 1699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.